CD274 and neoplasm: In the current study, we designed the CAR vector to contain the extracellular domain of an anti-PDL1 scFv derived from MEDI4736, an specific PD-L1 antagonistic monoclonal antibody that showed to potentiate T-cell mediated antitumor activity and improve the survival of tumor-bearing mice [34].